Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner
Zhiqiang Pan,Qi Zhang,Xiaodan Liu,Huimin Zhou,Tong Jin,Ling-Yun Hao,Ling Xie,Ming Zhang,Xiao-Xiao Yang,Meng-Lan Sun,Zhou-Ya Xue,Yang Tao,Xin-Chun Ye,Wen Shen,Jun-Li Cao
DOI: https://doi.org/10.1097/j.pain.0000000000002218
IF: 7.926
2021-01-26
Pain
Abstract:The methyltransferase-like 3 (<em>Mettl3</em>) is a key component of the large N6-adenosine-methyltransferase complex in mammalian responsible for RNA N6-methyladenosine (m<sup>6</sup>A) modification, which plays an important role in gene post-transcription modulation. Although RNA m<sup>6</sup>A is enriched in mammalian neurons, its regulatory function in nociceptive information processing remains elusive. Here, we reported that Complete Freund's Adjuvant (CFA)-induced inflammatory pain significantly decreased global m<sup>6</sup>A level and m<sup>6</sup>A writer <em>Mettl3</em> in the spinal cord. Mimicking this decease by knocking down or conditionally deleting spinal <em>Mettl3</em> elevated the levels of m<sup>6</sup>A in ten-eleven translocation methylcytosine dioxygenases 1 (<em>Tet1</em>) mRNA and TET1 protein in the spinal cord, leading to production of pain hypersensitivity. By contrast, overexpressing <em>Mettl3</em> reversed a loss of m<sup>6</sup>A in <em>Tet1</em> mRNA and blocked the CFA-induced increase of TET1 in the spinal cord, resulting in the attenuation of pain behavior. Furthermore, the decreased level of spinal YT521-B homology domain family protein 2 (YTHDF2), an RNA m<sup>6</sup>A reader, stabilized upregulation of spinal TET1 because of the reduction of <em>Tet1</em> mRNA decay by the binding to m<sup>6</sup>A in <em>Tet1</em> mRNA in the spinal cord after CFA. This study reveals a novel mechanism for downregulated spinal cord METTL3 coordinating with YTHDF2 contributes to the modulation of inflammatory pain through stabilizing upregulation of TET1 in spinal neurons.
neurosciences,clinical neurology,anesthesiology